* U.S. District Court ruled that Roxane Laboratories
infringed U.S. patent nos. RE39,198 and 8,586,610 by submitting
to FDA an ANDA
Source text for Eikon:
Further company coverage:
The post BRIEF-Vanda says U.S. District Court ruled Roxane Laboratories infringed certain patents appeared first on NASDAQ.